1. Home
  2. NUVL vs OLLI Comparison

NUVL vs OLLI Comparison

Compare NUVL & OLLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$100.82

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Ollie's Bargain Outlet Holdings Inc.

OLLI

Ollie's Bargain Outlet Holdings Inc.

HOLD

Current Price

$113.70

Market Cap

7.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
OLLI
Founded
2017
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.6B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
NUVL
OLLI
Price
$100.82
$113.70
Analyst Decision
Strong Buy
Buy
Analyst Count
15
13
Target Price
$135.00
$140.69
AVG Volume (30 Days)
497.6K
1.0M
Earning Date
02-27-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.35
EPS
N/A
3.61
Revenue
N/A
$2,537,026,000.00
Revenue This Year
N/A
$19.12
Revenue Next Year
N/A
$13.16
P/E Ratio
N/A
$31.88
Revenue Growth
N/A
12.58
52 Week Low
$55.54
$94.88
52 Week High
$113.02
$141.74

Technical Indicators

Market Signals
Indicator
NUVL
OLLI
Relative Strength Index (RSI) 49.64 56.03
Support Level $98.65 $106.52
Resistance Level $106.57 $117.01
Average True Range (ATR) 4.46 3.36
MACD -0.29 0.74
Stochastic Oscillator 47.36 86.64

Price Performance

Historical Comparison
NUVL
OLLI

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About OLLI Ollie's Bargain Outlet Holdings Inc.

Ollie's Bargain Outlet Holdings Inc is a retailer of closeout merchandise and excess inventory. The company sells name brand household related items that consumers use in their everyday lives at prices that are heavily discounted below traditional retailers. It offers customers a broad selection of brand name products, including housewares, bed and bath, food, floor coverings, health and beauty aids, books and stationery, toys, and electronics. It operates stores across the Eastern half of the United States. Its differentiated go-to-market plan is characterized by a fun and engaging treasure hunt shopping experience, compelling customer value proposition, and witty, humorous in-store signage and advertising campaigns.

Share on Social Networks: